聚烯亚类与前列腺癌之间的关联:观察性研究的系统审查和元分析
Yiping Huang1, Wenyan Wang2, Jianxiang Jin3
1Department of Urology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
Frontiers in nutrition
|August 15, 2024
概括
饮食中的多醇,特别是黄醇,黄醇和氨酸,与更高的前列腺癌 (PCA) 风险有关. 然而,血清/血多,如基因斯坦和肠乳,显示PCA的风险降低.
科学领域:
- 营养科学 营养科学
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 各种多类对前列腺癌 (PCA) 的影响仍然是争论的主题.
- 调查多类和PCA发病率之间的关联对于了解饮食对癌症风险的影响至关重要.
研究的目的:
- 系统地评估饮食,血清/血和尿路聚烯子类与前列腺癌发病率之间的关系.
- 为了澄清聚醇对PCA风险的有争议的影响.
主要方法:
- 在主要数据库 (PubMed,科学网,Embase,Cochrane图书馆) 进行了全面的系统搜索,截至2023年12月.
- 包括38个观察性研究 (11个队列,27个病例控制) 与824,933名参与者.
- 分析使用调整的几率比率 (OR) 和95%置信区间 (95%CI) 来评估关联.
主要成果:
- 饮食中的多醇,特别是黄醇,黄醇和氨酸,与PCA风险显著增加有关 (OR=1.01-1.06).
- 在饮食中的多醇和非局部或高档PCA之间没有发现显著的关联.
- 血清/血总聚醇,基因斯坦和肠乳与PCA风险降低有关 (OR=0.92-0.95).
结论:
- 多似乎通常会增加男性的前列腺癌风险,其影响因子类和形式而异 (饮食与血清/血).
- 饮食中摄入某些多可能会增加PCA风险,而血清/血水平可能会提供保护.
- 需要进一步的研究来阐明多类子类之间的复杂相互作用,它们的生物可用性和PCA发展.
更多相关视频
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
3.9K
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.2K
相关概念视频
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
